Nearly All Oncology Providers Report Prior Authorization Causing Delayed Care, Other Patient Harms
Prior authorization is harming individuals with cancer according to new survey results from the Association for Clinical Oncology (ASCO). Read
Lung Screening Saves Lives; Clues to Hyperprogression; Bacteria Foil Immunotherapy
Diagnosis of early-stage lung cancer with low-dose CT screening was associated with significant improvement in long-term survival. (Mount Sinai, Radiological Society of North
Implant Delivering Chemo To Brain May Help Patients With Incurable Cancers
Researchers have found a way to safely deliver a steady supply of chemotherapy directly to brain tumors -- in what
With Cancer, Small Gestures Count the Most
One day in September, my wife called out to me from the living room, “Darling, come here for a quick
Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers
After prior data showed that one in four patients with B-cell malignancies did not produce detectable antibodies after receiving their
End-of-Life Discussions Can ‘Lay Out a Roadmap’ of Patient Wishes and Avoid Unnecessary Cancer Care
End-of-life discussions are difficult but essential for patients with late-stage cancer, and having them early on and throughout the treatment
New Study Shows Segregation in U.S. Counties Influence Cancer Risk and Mortality
Researchers at the American Cancer Society stress improving access to cancer care to reduce disparities in cancer outcomes. Read the
Surgery For Hereditary Breast Cancer
Women with inherited mutations in breast cancer genes have lifetime varying breast cancer risks, ranging from high (e.g., 40% or
HIV-Positive Patients with Cancer May Have Accelerated Biological Aging
Patients with cancer who were living with human immunodeficiency virus (HIV) infection had increased epigenetic age—a type of biological age
Pfizer CEO Says Covid Vaccine Will Remain ‘Free For All Americans,’ Overlooking Indirect Costs
As Pfizer prepares to hike the price of its Covid-19 vaccines, the company’s CEO, Albert Bourla, maintained at a conference
